Insulin aspart
From Proteopedia
(Difference between revisions)
(New page: <StructureSection load='' size='340' side='right' caption='Caption for this structure' scene=''> Insulin aspart, sold under the brand name NovoLog and Fiasp, among others, is a modified ty...) |
|||
| (12 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| - | <StructureSection load='' size='340' side='right' caption=' | + | <StructureSection load='' size='340' side='right' caption='Human modified insulin complex with cresol Zn+2 and Cl-; PDB ID [[4gbc]]' scene='96/968809/Cv/3'> |
| - | Insulin aspart, sold under the brand name NovoLog and Fiasp, among others, is a modified type of medical insulin used to treat type 1 and type 2 diabetes. See also [https://en.wikipedia.org/wiki/Insulin_aspart]. | + | Insulin aspart, sold under the brand name NovoLog and Fiasp, among others, is a modified type of medical insulin used to treat type 1 and type 2 diabetes. See also [https://en.wikipedia.org/wiki/Insulin_aspart Insulin aspart] and [[Insulin]]. |
| + | |||
| + | <scene name='96/968809/Cv/4'>Hexamer of the human insulin variant B28Asp at pH 6.5</scene> (PDB ID [[4gbc]]). | ||
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> | ||
Current revision
| |||||||||||
